Abbrea Capital’s Schwab Emerging Markets Equity ETF SCHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-57,811
Closed -$1.46M – 244
2024
Q1
$1.46M Sell
57,811
-20,869
-27% -$513K 0.19% 97
2023
Q4
$1.95M Sell
78,680
-7,525
-9% -$181K 0.28% 77
2023
Q3
$2.06M Sell
86,205
-4,101
-5% -$102K 0.33% 67
2023
Q2
$2.22M Hold
90,306
– – 0.34% 63
2023
Q1
$2.21M Buy
90,306
+2,050
+2% +$50.8K 0.38% 61
2022
Q4
$2.09M Buy
88,256
+37,185
+73% +$866K 0.38% 64
2022
Q3
$1.14M Hold
51,071
– – 0.22% 95
2022
Q2
$1.3M Sell
51,071
-4,385
-8% -$115K 0.22% 92
2022
Q1
$1.54M Hold
55,456
– – 0.22% 93
2021
Q4
$1.64M Buy
55,456
+7,495
+16% +$229K 0.22% 90
2021
Q3
$1.46M Sell
47,961
-69
-0.1% -$2.16K 0.22% 89
2021
Q2
$1.58M Hold
48,030
– – 0.24% 85
2021
Q1
$1.53M Hold
48,030
– – 0.25% 82
2020
Q4
$1.47M Buy
48,030
+70
+0.1% +$2.03K 0.26% 78
2020
Q3
$1.28M Sell
47,960
-70
-0.1% -$1.87K 0.27% 80
2020
Q2
$1.17M Sell
48,030
-8,444
-15% -$192K 0.27% 79
2020
Q1
$1.17M Buy
+56,474
New +$1.41M 0.31% 76

Other funds holding SCHE

Abbrea Capital's SCHE Position: Q2 2024 in Review

Abbrea Capital sold out of Schwab Emerging Markets Equity ETF (SCHE) in Q2 2024, closing a stake of 57,811 shares — an estimated $1.46M sold.

Abbrea Capital first reported a position in SCHE in Q1 2020 and held it in 17 quarters. The position peaked at $2.22M in Q2 2023. 722 funds tracked by Wall St. Rank hold SCHE as of Q2 2024.

  • Abbrea Capital reported no remaining Schwab Emerging Markets Equity ETF position as of Q2 2024 after selling out during the quarter.
  • Abbrea Capital sold 57,811 Schwab Emerging Markets Equity ETF shares in Q2 2024, an estimated $1.46M.
  • Abbrea Capital first reported a position in Schwab Emerging Markets Equity ETF in Q1 2020 and held it in 17 quarters.
  • Abbrea Capital's Schwab Emerging Markets Equity ETF position peaked at $2.22M in Q2 2023.
  • 722 funds tracked by Wall St. Rank held Schwab Emerging Markets Equity ETF as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.